×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
吉林大学白求恩第一医... [3]
西安交通大学 [2]
山东大学 [2]
吉林大学白求恩第三医... [2]
复旦大学上海医学院 [2]
厦门大学 [1]
更多...
内容类型
期刊论文 [18]
发表日期
2019 [6]
2018 [1]
2017 [2]
2016 [3]
2014 [3]
2013 [2]
更多...
学科主题
Rheumatolo... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共18条,第1-10条
帮助
限定条件
内容类型:期刊论文
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/12/04
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2019/12/05
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Li, X.
;
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2019/12/05
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 页码: 227-234
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/11/19
rheumatoid arthritis
certolizumab pegol
tumour necrosis factor-alpha
DMARD
Chinese
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2, 页码: 227-234
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/11
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid
arthritis
Chinese
Efficacy and Safety of Novel Targeted Synthetic DMARD and Biological DMARD in Active Psoriatic Arthritis: A Systematic Review, Meta-Analysis, and Network Meta-Analysis
期刊论文
ARTHRITIS & RHEUMATOLOGY, 2018, 卷号: Vol.70
作者:
Lu, Chenyang
;
Wallace, Beth I.
;
Fu, Wenyi
;
Liu, Yi
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/02/25
The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study
期刊论文
CLINICAL RHEUMATOLOGY, 2017, 卷号: 36, 期号: 1
作者:
Liu, Yi
;
Li, Juan
;
Wu, Lijun
;
He, Dongyi
;
Liu, Tian
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/05
Biological
China
DMARD
Duration
Rheumatoid arthritis
Therapy
The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study
期刊论文
CLINICAL RHEUMATOLOGY, 2017, 卷号: 36, 页码: 35-43
作者:
An, Yuan
;
Liu, Tian
;
He, Dongyi
;
Wu, Lijun
;
Li, Juan
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/11/26
Rheumatoid arthritis
China
Therapy
Duration
Biological
DMARD
High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT) A multicenter randomized clinical trial
期刊论文
MEDICINE, 2016, 卷号: 95, 期号: 28
作者:
Li, Ru
;
Zhao, Jin-Xia
;
Su, Yin
;
He, Jing
;
Chen, Li-Na
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/05
DMARDs (synthetic)
outcomes research
rheumatoid arthritis
©版权所有 ©2017 CSpace - Powered by
CSpace